Test Identifies Babies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stem Cells Heal Intestinal Disease in Premature Infants
by Colleen Fleiss on 
May 1, 2021 at 1:16 AM
A human placental-derived stem cell (hPSC) therapy strategy is found to treat necrotizing enterocolitis (intestinal bowel disease) that affects up to 10 percent of premature infants.
The intestinal bowel disease is at a very vulnerable and developmentally crucial time can lead to serious infection and death.
The cause of necrotizing enterocolitis is unclear - it is a multi-faceted disease that results from the complex interaction of early bacterial colonization, an exaggerated inflammatory response, and immature intestinal tissue.
‘Necrotizing enterocolitis is a life-threatening intestinal disease that is a leading cause of mortality in premature infants and treatment options remain elusive.’ ....

United States , Anthony Atala , American Physiological Society , American Journal , Liver Physiology , Test Identifies Babies , Most Risk , Necrotizing Enterocolitis , Enterocolitis Prevented With Growth Factors , Milk Based Fortifiers Improve Health Outcome , Respiratory Syncytial Virus , Blood Stem Cells , Parkinsons Disease Surgical Treatmentgenetics , ஒன்றுபட்டது மாநிலங்களில் , அந்தோணி அதல , அமெரிக்கன் உடலியல் சமூகம் , அமெரிக்கன் இதழ் , கல்லீரல் உடலியல் , பெரும்பாலானவை ஆபத்து , இரத்தம் தண்டு செல்கள் ,